{
  "id": "9529e0333fa9fe12",
  "title": "Lynozyfic\u2122 ( linvoseltamab ) Monotherapy in Newly Diagnosed Multiple Myeloma ( NDMM ) Shows Impressive Responses , Supporting Rationale as a Potential Foundation in Frontline Treatment",
  "description": "20251208T003000Z",
  "content": "",
  "source": "manilatimes.net",
  "source_url": "https://www.manilatimes.net/2025/12/08/tmt-newswire/globenewswire/lynozyfic-linvoseltamab-monotherapy-in-newly-diagnosed-multiple-myeloma-ndmm-shows-impressive-responses-supporting-rationale-as-a-potential-foundation-in-frontline-treatment/2238548",
  "published_at": "20251208T003000Z",
  "fetched_at": "2025-12-09T00:22:19.510482+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [],
  "location": "Philippines",
  "raw_data": {
    "url": "https://www.manilatimes.net/2025/12/08/tmt-newswire/globenewswire/lynozyfic-linvoseltamab-monotherapy-in-newly-diagnosed-multiple-myeloma-ndmm-shows-impressive-responses-supporting-rationale-as-a-potential-foundation-in-frontline-treatment/2238548",
    "url_mobile": "https://www.manilatimes.net/2025/12/08/tmt-newswire/globenewswire/lynozyfic-linvoseltamab-monotherapy-in-newly-diagnosed-multiple-myeloma-ndmm-shows-impressive-responses-supporting-rationale-as-a-potential-foundation-in-frontline-treatment/2238548/amp",
    "title": "Lynozyfic\u2122 ( linvoseltamab ) Monotherapy in Newly Diagnosed Multiple Myeloma ( NDMM ) Shows Impressive Responses , Supporting Rationale as a Potential Foundation in Frontline Treatment",
    "seendate": "20251208T003000Z",
    "socialimage": "https://www.manilatimes.net/manilatimes/uploads/images/2025/12/08/857718.jpg",
    "domain": "manilatimes.net",
    "language": "English",
    "sourcecountry": "Philippines"
  }
}